Seeking Alpha
21 Oct 2026, 01:34 UTC · 1h ago
Auna: Improving Hospital Volumes And Attractive Valuation Support A Strong Buy
Impact · against what's priced in
Auna's preliminary Q3 surgery growth of 11.7% provides a concrete catalyst for the expected EBITDA margin recovery in H2 2026. While the valuation and deleveraging potential are noted, the specific volume acceleration acts as the primary driver for a price adjustment.
- AUNA+0.60
No priced-in read yet
- In context
Preliminary Q3 results showing an 11.7% year-over-year increase in surgeries provide tangible evidence that hospital volume is recovering, supporting the projected EBITDA margin rebound for the second half of 2026.
Read from the article alone
Top 1 mover · tap to explore
